EKIVF yields 3.65% · PFE yields 6.13%● Live data
📍 EKIVF pulled ahead of the other in Year 1
Combined, EKIVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EKIVF + PFE for your $10,000?
Enka Insaat ve Sanayi A.S., together with its subsidiaries, operates as a construction company in Turkey, Russia, Kazakhstan, Georgia, Iraq, and internationally. It operates through four segments: Construction, Rental, Energy, and Trading and Manufacturing. The company engages in the construction of industrial and social buildings, and motorways; construction and operation of natural gas fired electrical energy generation facilities; and investment in and development of real estate properties and shopping malls. It is also involved in the marketing and after-sale service of construction machineries, trucks, industrial products, and spare parts; manufacturing of structural steel works; installation and establishment of the technical equipment; and excavation backfilling works and quarrying crushing operation of highway projects. In addition, the company engages in the pile dwelling work; base and superstructure construction; slip form and construction of drilling and ground surveys; organization of conventions and seminars; tour reservations and tickets sales; production of ready-mixed concrete; production and sale of electricity; repair and maintenance of power plants; and provision of architectural design and air transportation services, as well as trading activities. Further, it is involved in various activities, such as material handling and storage systems, auxiliary facilities, water treatment and environmental engineering, infrastructure and construction, control systems, and instrumentation engineering activities. Enka Insaat ve Sanayi A.S. was incorporated in 1957 and is headquartered in Istanbul, Turkey.
Full EKIVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.